Huma

Healthcare doesn’t just need digital applications—it needs trust. Because in healthcare, unregulated innovation costs lives. At Huma, we make building regulated, AI-driven healthcare software easy. The platform powers software built across 70+ countries, enabling organisations to build applications that make care proactive, predictive, and personal. AI’s potential is clear—yet the Breakthrough Study by Leaps by Bayer, Boston Consulting Group (BCG), and Ipsos shows trust falls where AI advances fastest. That’s the frontier. Trust isn’t a feature. It’s the foundation of scalable, regulated, clinical AI. In his latest article, CEO Dan Vahdat shares why confidence in regulated, clinical AI is not a feature—it's the foundation. Read more: https://lnkd.in/ebn_-6E5

🚀Full enrollment. One year early. 4,500 patients recruited.🚀 Our latest chronic kidney disease and type 2 diabetes clinical trial, powered by the Huma Cloud Platform and our amazing team, completed enrollment ahead of schedule by removing the friction that slows research down. We automated EHR-to-EDC data transfer across 350 sites in 20 countries. Patient variables now flow directly into the database. No manual entry. No delay. Physicians focus on patients, not paperwork. Data quality improves. Timelines compress. This is real-world evidence at scale. It closes the gap between what works in controlled trials and what works in everyday practice for chronic kidney disease and type 2 diabetes. Finishing early is not chance. It is process, rebuilt. #RealWorldEvidence #ClinicalInnovation

💡Emergency Care. Reimagined. In 2022, Homerton Healthcare NHS Foundation Trust University Hospital became one of the first pioneers to launch digital triage. Three years on, the partnership is stronger than ever. The impact on patient care has been phenomenal. The contract is renewed. Today, eTriage is live across 21 NHS Emergency Departments and Urgent Care Centres, with 1.8M+ patients safely triaged. And this is not the end state. With Homerton Healthcare NHS Foundation Trust, we are driving Emergency Care triage further. Iteration after iteration. AI-powered refinement. A system that learns, adapts, and expands what’s possible. #UKHealthcare #NHS #DigitalTriage #EmergencyCare #AIinHealthcare

As world leaders gather this week for the United Nations General Assembly High-Level Meeting on non-communicable diseases (NCDs), I’m honoured to join a group of 25 global leaders—from governments, health systems, industry, NGOs, and academia—to outline both the urgency of the crisis and the scalable solutions within our reach. NCDs are responsible for 74% of all deaths globally. They pose a growing threat not only to public health, but to economic resilience and social equity worldwide. At Huma , we’re working to reverse that trend by reimagining how we prevent, monitor, and manage chronic disease—through advanced technology, real-world data, and trusted partnerships with health systems around the world. In an Open Letter published in POLITICO , we call for collective action around three critical priorities: - Investing in health for a sustainable future - Strengthening health systems for greater resilience - Prioritising innovation to improve access and outcomes This is a pivotal moment. The tools exist. The partnerships are forming. Now is the time to act. Read the Open Letter here: https://lnkd.in/efQdu_7J #UNGA #GlobalHealth #NCDs #HealthInnovation #DataForGood #ChronicDisease #FutureOfHealth #Huma

Rehabilitation for paraplegia has been trapped in repetition: treadmills, crutches, slow gains measured in inches. That era is ending. The EFeQT study — funded by Germany’s Federal Joint Committee (G-BA) with treatment costs covered by statutory health insurance — will test whether neuromuscular feedback therapy can outperform conventional physiotherapy on walking ability in patients with incomplete paraplegia. This study is the newest to run on the disease-agnostic Huma Cloud Platform — the backbone of modern digital health software. We are proud to empower their work in this disease area, and to prove again that regulated, healthcare software can be deployed at speed and at scale. Learn more: https://lnkd.in/eF7e6JyP

Huma has been named one of TIME’s World’s Top HealthTech Companies 2025 in AI & Data. We take this as recognition not of us, but of the hospitals, life sciences leaders, and health systems we serve. They are the ones moving first, building healthcare that is smarter, more resilient, and built to last on top of the Huma Cloud Platform. #HealthTech #AI

🚀 Transform Patient Engagement with Purpose-Built Digital Health Solutions Why do some digital health programs achieve 65-79% engagement rates while others struggle to maintain patient interest? Our latest internal analysis reveals a game-changing insight: The success of digital health programs isn't about technology—it's about relevance. 📊 The Data Speaks Clearly: ✅ Generic approaches: Declining engagement over time ✅ Specialized, disease-focused solutions: 65% sustained daily engagement ✅ Clinician-integrated programs: Exceptional 65%+ engagement rates 🎯 The Huma Cloud Platform Advantage: 🔧 Bespoke Widget Library Deploy condition-specific tools that matter—surgical checklists, symptom calculators, treatment decision aids—not generic content that patients ignore. 👩⚕️ Seamless Clinical Integration Transform your app from a "nice-to-have" into an essential care component through our dedicated clinician portal and real-time monitoring capabilities. 📈 Proven Results Across Therapeutic Areas From oncology to rare diseases, our modular architecture delivers measurable patient outcomes and superior engagement metrics. 💡 The Strategic Difference: "Patient engagement correlates strongly with solution sophistication and healthcare provider integration. The most significant determinant of program success is positioning digital tools as integral care components rather than standalone consumer products." 🌟 Your Next Digital Health Project Deserves: -Disease-specific functionality that addresses real patient journey moments -Clinical workflow integration that enhances provider efficiency -Scalable platform architecture that grows with your program needs -Real-world evidence generation that supports market access Ready to move beyond generic solutions? The Huma Cloud Platform's extensibility and specialized widget ecosystem ensure your pharmaceutical digital health investment delivers meaningful patient outcomes and superior business value. #DigitalHealth #HealthTech #PatientEngagement #PharmaInnovation #LifeSciences #FutureOfHealth #PatientCentricCare #RemotePatientMonitoring #ClinicalIntegration #HealthcareAI #DigitalTherapeutics #MedTech #HealthEquity #SmartHealthcare #HealthcareInnovation #PatientExperience #OncologyCare #RareDiseaseInnovation #RealWorldEvidence #SaMD

✨ We’re honored and excited to share that Huma has been nominated for two categories at the 2025 European Lifestars Awards: 🏆 Healthtech of the Year 🏆 M&A of the Year These nominations recognize the collective efforts of our incredible team and partners in advancing digital-first and AI-powered healthcare, transforming how care and research are delivered worldwide. The European Lifestars Awards celebrate organizations driving true impact across life sciences — and we’re proud to be standing alongside such inspiring innovators and changemakers. 📅 Winners will be revealed on 17 November at City Central at the HAC in London — we look forward to celebrating with the community!

🚨 Nearly 50% of clinical trials fail before reaching Phase II. For biotech companies, early planning isn’t just smart—it’s survival. In a funding landscape where 48% of biotechs face capital challenges, even small missteps in protocol design, endpoint selection, or patient recruitment can derail promising science before it has a chance to prove itself. At Huma, we support biotech innovators from day one—through our own platform and across our specialist portfolio, including Alcedis - a HUMA company, our clinical trial partner with deep expertise in early-phase planning and execution. 📘 Our latest whitepaper—developed by the Alcedis - a HUMA company team—offers practical guidance for de-risking early development: 🔹 Align protocols with your long-term regulatory and commercial strategy 🔹 Select endpoints that attract both regulators and investors 🔹 Accelerate patient recruitment and generate high-quality data 🔹 Navigate regulatory hurdles with foresight—not trial-and-error 💸 And to help the most promising biotech companies get off the ground faster, Huma and Alcedis are contributing up to 25% of study costs for selected early-phase trials. If you’re preparing for a trial—or even considering one—this is your chance to build it right from the start. 👉 Download the full whitepaper and unlock a smarter path to success: 🔗 https://lnkd.in/eV3xzdbp #Biotech #ClinicalTrials #Pharma #DigitalHealth #Huma #Alcedis #EarlyPhase #TrialDesign #DecentralizedTrials #Innovation #LifeSciences

🏥🚀 Exciting News! Huma has been recognized as part of the Startup Coalition’s £32B HealthTech Index—a data-driven snapshot of the UK’s thriving healthtech ecosystem. The newly launched HealthTech Index highlights 1,000 top startups driving innovation and impact in healthcare. As a sector, UK healthtech: 💸 Raised £27.4B in funding 📈 Valued at £32B in 2024 👩💻 21% of companies are female-founded 👥 Created 30,000 jobs 🤝 Achieved 168 exits We’re proud to be part of a sector that’s transforming healthcare—making it more connected, efficient, and patient-centric. 📝 Read the full report here: https://lnkd.in/eH8cAEHj Here’s to the innovators, the changemakers, and the future of health! 🌍✨